SlideShare a Scribd company logo
BIPIN KOIRALA
MASTER’S OF OPTOMETRY
HIMALAYA EYE INSTITUTE
 Introduction
 Epidemiology
 Classification
 Treatment
 References
 With the introduction of advanced neonatal
life support, survival of preterm neonates
has increased significantly.
 Prematurity and low birth weight carries a
significant risk factor for ocular morbidity.
 Retinopathy of prematurity (ROP) is an
emerging cause of blindness in the
developed country.
 Retinopathy of prematurity (ROP) is a bilateral
proliferative retinopathy, occurring in
premature infants with low birth weight who
often have been exposed to high concentration
of oxygen.
 Well known as Retrolental fibroplasia
 ROP, was first correlated with prematurity by
Terry in 1942.
 Originally described as “Retrolental Fibroplasia”.
 The term “ Retinopathy of Prematurity “ was first
suggested by Heath in 1952.
• Nearly disappeared between 1954-1970,
when oxygen use severely restricted.
• But now, has returned, secondary to
improved neonatal practice of LBW infants.
 Every year, an estimated 15 million babies
are born preterm (normal gestation is 37–
42 weeks)
 Approximately 20,000 of these babies will
become blind from retinopathy of
prematurity (ROP) every year
 An additional 12,300 will be left with visual
impairment.
 Countries with the highest number of
preterm births are India, China, Nigeria,
Pakistan and Indonesia.
 East Asia, South East Asia, and the Pacific
are the regions with the highest number of
preterm babies who survive, and the
highest number who develop visual loss
from ROP
 A total of 55 babies fulfilled the screening
criteria. ROP was present in 25.45% (n=14)
of the babies. Threshold disease was noted
in 5.45% (n=3) of the babies screened. Low
birth weight (p<0.01) and low gestational
age (p<0.01) was significantly associated
with the incidence of ROP.
 Oxygen supplementation (p=<0.01) was an
independent risk factor.
Retinopathy of prematurity in a tertiary care hospital in eastern Nepal
S Adhikari 1, B P Badhu, N K Bhatta, R S Rajbhandari, B K Kalakheti
 Gestational age ( < 32 weeks).
 Birth weight of the baby.
(< 1500g and especially <1250g).
 The amount of time in oxygen therapy.
 Sepsis,
 Multiple blood transfusions,
 Multiple births
 Hyaline membrane disease,
 Use of Antibiotics,
 Apnoea,
 Low pH,
 Ultraviolet light therapy, etc
Various theories proposed are:
1. The Classical Theory
2. Gap Junction Theory
3. Current VEGF Theory
 The nasal retina is normally fully vascularized
after 8 months of gestation, the temporal
periphery at or by 1 month after delivery.
 Vascular endothelial growth factor (VEGF) is
believed to play an important role in the
vascularization process.
 Two Process of Vascularization:
1. Vasculogenesis: formation of new vessels by
transformation of vascular precursor cells
2. Angiogenesis: budding from existing vessels
 Interaction between IGF-1 and VEGF has been
studied and proposed to play a role in the
pathogenesis of ROP
 Hyperoxia in the retina will cause retinal
vasoconstriction
 If sustained will cause some degree of
vascular closure and injury to endothelial
cells of the most immature vessels.
 It leads to subsequent hypoxia
 later with growing age increase in retinal
metabolic demand will lead to upsurge of
VEGF
 leading to abnormal neo vascularization
 Nodules of proliferating endothelial cells from
residual vascular complexes adjacent to retinal
capillaries ablated during hyperoxia canalize to
form new vessels
 These vessels not only grow within the retina,
but also erupt through ILM to grow on its
surface.
 A circle drawn on the posterior pole, with the
optic disc as the centre and twice the
discmacula distance as the radius, constitutes
zone I.
 Any ROP in this zone is usually very severe
because of a large peripheral area of
avascular retina
 A circle is drawn with the optic disc as the
centre and disc to nasal Oraserrata as the
radius. The area between zone I and this
boundary constitutes zone II.
 The temporal arc of retina left beyond the
radius of zone II is zone III.
 The condition has been divided into active ROP
and cicatricial ROP.
 Clinically the evolution of the active ROP has
been divided into five stages
ROP
STAGE 1 STAGE 2 STAGE 3 STAGE 4 STAGE 5
 It is characterised by formation of a demarcation
line dividing the vascular from the avascular
retina.
 It is a thin, flat, tortuous, grey-white line running
roughly parallel with the ora serrata.
 It is more prominent in the temporal periphery.
 Ridge arises in the region of the demarcation
line
 Ridge is a scar tissue
 It has height and width, and extends above the
plane of the retina.
 Blood vessels enter the ridge and small isolated
neovascular tufts may be seen posterior to it
 It is characterised by a ridge with extraretinal
fibrovascular proliferation into the vitreous.
 This stage is further subdivided into mild,
moderate and severe, depending on the
amount of fibrovascular proliferation.
 The highest incidence of this stage is around
the post-conceptual age of 35 weeks
 It is a stage of subtotal retinal detachment
 Sub divided into stage 4a and stage 4b
 Stage 4a: It includes subtotal retinal detachment
not involving the macula.
 Stage 4b: It includes subtotal retinal detachment
involving the macula
 It is marked by total retinal detachment which
is always funnel-shaped.
 RD is due to exudation from poorly developed
new vessels
 RD can also be due to fibro vascular traction
 It refers to presence of tortuous dilated
vessels at posterior pole with any stage of
ROP.
 Shows tendency to progress rapidly to Stage
3 (or greater).
 Associated with it is the engorgement and
dilatation of iris vessels, which result in
poor pharmacological dilatation of pupil.
 There is a spectrum of abnormal dilatation
and tortuosity of which Plus disease is the
severe form.
 Pre-plus disease was later described as
vascular abnormalities of the posterior pole
that are insufficient for the diagnosis of plus
disease
 But that demonstrate more arterial tortuosity
and more venous dilatation than normal.
 The ETROP trial classified pre threshold ROP
into:
 Type 1 ROP
Zone I, any stage with plus disease.
Zone I, stage 3 without plus disease.
Zone II, stage 2 or 3 with plus disease..
Type 2 disease
 Requires observation
 Stage 1 or 2 in zone I without plus disease.
 Stage 3 ROP within zone II without plus
disease.
 Treatment is now recommended within 72
hours for prethreshold type I.
 Threshold disease refers to stage 3 plus disease
involving 5 continuous or 8 discontinuous clock
hours.
 This stage needs laser or cryotherapy in less
than 72 hours
 Recommended that a fundus examination be
performed on infants:
 Who have a gestational age of 30 weeks or
less.
 A birth weight of less than 1500g.
 Birth weight of 1500-2000g with an oxygen
supplementation requirement or an unstable
course.
 The first examination performed at 4 weeks
 Or at less than 5 weeks after birth or at a
corrected gestational age of 30 to less than
31 weeks, whichever is later.
 Follow-up examinations should be done every
1-2 weeks thereafter until retinal vessels have
grown normally into zone III
 Or until the risk of developing ROP has passed
i.e.(about 44 – 46 weeks ).
 If the normal blood vessels stop growing into
the periphery of the retina
 Or if ROP begins to develop, examinations are
performed more frequently, either weekly or
twice a week.
 A lid speculum may be necessary and scleral
depression is often required.
 Proparacaine can be used to provide topical
anesthesia if desired
 Pupillary dilatation with one drop each of
cyclopentolate 0.5%, phenylephrine 2%
 Indirect Ophthalmoscopy with + 20 D
 Important to be aware of the infant's status
during and immediately after the
examination
 As the examination can be stressful and be
associated with bradycardia
 Treatment guidelines are based especially
upon
 CRYO-ROP study
 ETROP STUDY
 Cryotherapy
◦ For threshold ROP (stage 3 in at least 5 clock
hours with plus disease)
◦ Freezing the sclera with cold probe.
◦ Multiple applications are done to the entire
avascular area anterior to the neovascular
ridge.
Treatment of the ridge itself is avoided,
since the ridge tends to bleed and cause
vitreous hemorrhage if frozen.
Procedure is painful and done under general
anesthesia.
Complications: Anesthesia problems; Eyelid
and conjunctivae edema
Laser photocoagulation
Laser treatment for ROP is similar to cryotherapy.
 The laser spot size is smaller than a spot of
cryotherapy.
Usually 600-1000 spots of laser as compared to
30-50 spots of cryotherapy needed.
Laser is a direct treatment of the retina and
its underlying tissue
Instead of the entire thickness of the eye
wall like in cryotherapy.
Most ophthalmologists treating ROP are
now using laser.
Scleral buckling:
For shallow retinal detachment - placing a
silicone band around the equator of the eye
to relieves the traction of the vitreous gel.
Vitrectomy:
 For complete retinal detachment.
 After the vitreous has been removed, the
scar tissue on the retina can be peeled or cut
away, allowing the retina to relax and lay
back down against the eye wall and to re-
attached.
 The success rate ranges from 25% to 50% of
patients undergoing surgery.
 The functional success rate is significantly
lower.
Intravitreal Injection of Bevacizumab (Avastin).
 It has been used for the treatment of ROP but
not well established
 Zone I disease is more likely to respond than
zone II.
 Allowing retinal development to proceed
normally without the destruction integral to
laser treatment is a potential advantage.
 Retinal Dragging
 Retinal folds
 Late onset RD
 Glaucoma
 Myopia, Strabismus, Amblyopia
 Controlling pain,
 Careful use of oxygen,
 Preventing infection,
 Improving nutrition by offering babies breast milk,
 Good temperature control and
 Supportive practices to keep babies comfortable
and stable, such as kangaroo care.
 Kanski clinical ophthalmology
 AAO eyewiki
 Internet sources
 Any Questions???
 oxygen saturation levels must be monitored and
kept at less than 95% to prevent reactive oxygen
species-related diseases, such as retinopathy of
prematurity and bronchopulmonary dysplasia. At
the same time, desaturation below 80 to 85%
must be avoided to prevent adverse
consequences, such as cerebral palsy. It is still
unclear what range of oxygen saturation is
appropriate for premature infants; however, until
the results of further studies are available, a
reasonable target for pulse oxygen saturation
(SpO2) is 90 to 93% with an intermittent review of
the correlation between SpO2 and the partial
pressure of arterial oxygen tension (PaO2).
 The experiment consisted of two runs: one
was a verbal cognition task, with normal air
(21% oxygen) administered and the other was
with hyperoxic air (30% oxygen)
administered.
 Hyper oxic …spo2 increaees

More Related Content

What's hot

retinopathy of prematurity
retinopathy of prematurityretinopathy of prematurity
retinopathy of prematurity
Rohit Rao
 
Pediatric cataract
Pediatric cataractPediatric cataract
Pediatric cataract
Dr. Ajay Kumar Singh
 
ROP current understanding and management
ROP current understanding and managementROP current understanding and management
ROP current understanding and management
Farhadul Alam
 
Squint
SquintSquint
Vitreous hemorrhage
Vitreous hemorrhageVitreous hemorrhage
Vitreous hemorrhage
poojamdm
 
Evaluation of squint
Evaluation of squint Evaluation of squint
Evaluation of squint
Dr.Siddharth Gautam
 
retinopathy of prematurity
retinopathy of prematurityretinopathy of prematurity
retinopathy of prematurity
Maruthi Upputuri
 
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurityPaavan Kalra
 
Hyphema
HyphemaHyphema
Leukocoria (White Pupillary Reflex)
Leukocoria (White Pupillary Reflex) Leukocoria (White Pupillary Reflex)
Leukocoria (White Pupillary Reflex)
Mohamed Abdelmongy
 
seminar on ROP - retinopathy of prematurity
seminar on ROP - retinopathy of prematurityseminar on ROP - retinopathy of prematurity
seminar on ROP - retinopathy of prematurity
Dr. Habibur Rahim
 
Childhood cataracts
Childhood cataractsChildhood cataracts
Childhood cataracts
Panit Cherdchu
 
Retinal detachment
Retinal detachment  Retinal detachment
Retinal detachment
priyanka singh
 
Hypertensive Retinopathy
Hypertensive RetinopathyHypertensive Retinopathy
Hypertensive RetinopathySanasaleem2
 
Management of retinal detachment
Management of retinal detachmentManagement of retinal detachment
Management of retinal detachment
Amreen Deshmukh
 
Management of Cataract
Management of CataractManagement of Cataract
Management of Cataract
Kevin Ambadan
 

What's hot (20)

retinopathy of prematurity
retinopathy of prematurityretinopathy of prematurity
retinopathy of prematurity
 
Congenital cataract
Congenital cataractCongenital cataract
Congenital cataract
 
Pediatric cataract
Pediatric cataractPediatric cataract
Pediatric cataract
 
ROP current understanding and management
ROP current understanding and managementROP current understanding and management
ROP current understanding and management
 
Squint
SquintSquint
Squint
 
Vitreous hemorrhage
Vitreous hemorrhageVitreous hemorrhage
Vitreous hemorrhage
 
Evaluation of squint
Evaluation of squint Evaluation of squint
Evaluation of squint
 
Retinopathy of prematurity 2014 july 11
Retinopathy of prematurity 2014 july 11Retinopathy of prematurity 2014 july 11
Retinopathy of prematurity 2014 july 11
 
retinopathy of prematurity
retinopathy of prematurityretinopathy of prematurity
retinopathy of prematurity
 
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurity
 
retinopathy of prematurity
retinopathy of prematurityretinopathy of prematurity
retinopathy of prematurity
 
Hyphema
HyphemaHyphema
Hyphema
 
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurity
 
Leukocoria (White Pupillary Reflex)
Leukocoria (White Pupillary Reflex) Leukocoria (White Pupillary Reflex)
Leukocoria (White Pupillary Reflex)
 
seminar on ROP - retinopathy of prematurity
seminar on ROP - retinopathy of prematurityseminar on ROP - retinopathy of prematurity
seminar on ROP - retinopathy of prematurity
 
Childhood cataracts
Childhood cataractsChildhood cataracts
Childhood cataracts
 
Retinal detachment
Retinal detachment  Retinal detachment
Retinal detachment
 
Hypertensive Retinopathy
Hypertensive RetinopathyHypertensive Retinopathy
Hypertensive Retinopathy
 
Management of retinal detachment
Management of retinal detachmentManagement of retinal detachment
Management of retinal detachment
 
Management of Cataract
Management of CataractManagement of Cataract
Management of Cataract
 

Similar to Retinopathy of prematurity.pptx

ROP salman.pptx
ROP salman.pptxROP salman.pptx
ROP salman.pptx
Salman Khan
 
Rop seminar
Rop seminarRop seminar
Rop seminar
ketan bhardwaj
 
RETINOPATHY OF PREMATURITY
RETINOPATHY OF PREMATURITYRETINOPATHY OF PREMATURITY
RETINOPATHY OF PREMATURITY
Faisal Anwar
 
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurity
Kanchan Gawade
 
Retinopathy of Prematurity (ROP) - classification and treatments
Retinopathy of Prematurity (ROP) - classification and treatmentsRetinopathy of Prematurity (ROP) - classification and treatments
Retinopathy of Prematurity (ROP) - classification and treatments
Aniruddha Rode
 
rop.pptx
rop.pptxrop.pptx
rop.pptx
Harshika Malik
 
final ROP seminar (1).pptx
final ROP seminar (1).pptxfinal ROP seminar (1).pptx
final ROP seminar (1).pptx
Farah Naz Dola
 
RETINOPATHY OF PREMATURITY
RETINOPATHY OF PREMATURITYRETINOPATHY OF PREMATURITY
RETINOPATHY OF PREMATURITY
Drhunny88
 
Retinopathy of prematurity vpr.pptx
Retinopathy of prematurity vpr.pptxRetinopathy of prematurity vpr.pptx
Retinopathy of prematurity vpr.pptx
Vishnu645963
 
seminar on Retinopathy of prematurity by Dr Anindita bose
seminar on Retinopathy of prematurity by Dr Anindita boseseminar on Retinopathy of prematurity by Dr Anindita bose
seminar on Retinopathy of prematurity by Dr Anindita bose
Dr. Habibur Rahim
 
Retinopathy of Primaturity
Retinopathy of PrimaturityRetinopathy of Primaturity
Retinopathy of Primaturity
Khulesh Sahu
 
Rop hearing
Rop hearingRop hearing
Rop hearing
Dr Praman Kushwah
 
ROP_Dr. Pradeep Bastola.pptx
ROP_Dr. Pradeep Bastola.pptxROP_Dr. Pradeep Bastola.pptx
ROP_Dr. Pradeep Bastola.pptx
Dr. Pradeep Bastola
 
Retinopathy of prematurity by dr sonali paradhi mhatre
Retinopathy of prematurity  by dr sonali paradhi mhatreRetinopathy of prematurity  by dr sonali paradhi mhatre
Retinopathy of prematurity by dr sonali paradhi mhatre
Sonali Paradhi Mhatre
 
RETINOPATHY OF PREMATURITY
RETINOPATHY OF PREMATURITY RETINOPATHY OF PREMATURITY
RETINOPATHY OF PREMATURITY
MEDICS india
 
ROP.pptx
ROP.pptxROP.pptx
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurity
Rasika Walpitagamage
 
Retinopathy Of Prematurity
Retinopathy Of PrematurityRetinopathy Of Prematurity
Retinopathy Of Prematurity
likuta
 
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurity
ROHIT KHATRI
 
Journal reading: Intravitreal bevacizumab for ROP : refractive error results
Journal reading: Intravitreal bevacizumab for ROP : refractive error resultsJournal reading: Intravitreal bevacizumab for ROP : refractive error results
Journal reading: Intravitreal bevacizumab for ROP : refractive error results
Olly Congga
 

Similar to Retinopathy of prematurity.pptx (20)

ROP salman.pptx
ROP salman.pptxROP salman.pptx
ROP salman.pptx
 
Rop seminar
Rop seminarRop seminar
Rop seminar
 
RETINOPATHY OF PREMATURITY
RETINOPATHY OF PREMATURITYRETINOPATHY OF PREMATURITY
RETINOPATHY OF PREMATURITY
 
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurity
 
Retinopathy of Prematurity (ROP) - classification and treatments
Retinopathy of Prematurity (ROP) - classification and treatmentsRetinopathy of Prematurity (ROP) - classification and treatments
Retinopathy of Prematurity (ROP) - classification and treatments
 
rop.pptx
rop.pptxrop.pptx
rop.pptx
 
final ROP seminar (1).pptx
final ROP seminar (1).pptxfinal ROP seminar (1).pptx
final ROP seminar (1).pptx
 
RETINOPATHY OF PREMATURITY
RETINOPATHY OF PREMATURITYRETINOPATHY OF PREMATURITY
RETINOPATHY OF PREMATURITY
 
Retinopathy of prematurity vpr.pptx
Retinopathy of prematurity vpr.pptxRetinopathy of prematurity vpr.pptx
Retinopathy of prematurity vpr.pptx
 
seminar on Retinopathy of prematurity by Dr Anindita bose
seminar on Retinopathy of prematurity by Dr Anindita boseseminar on Retinopathy of prematurity by Dr Anindita bose
seminar on Retinopathy of prematurity by Dr Anindita bose
 
Retinopathy of Primaturity
Retinopathy of PrimaturityRetinopathy of Primaturity
Retinopathy of Primaturity
 
Rop hearing
Rop hearingRop hearing
Rop hearing
 
ROP_Dr. Pradeep Bastola.pptx
ROP_Dr. Pradeep Bastola.pptxROP_Dr. Pradeep Bastola.pptx
ROP_Dr. Pradeep Bastola.pptx
 
Retinopathy of prematurity by dr sonali paradhi mhatre
Retinopathy of prematurity  by dr sonali paradhi mhatreRetinopathy of prematurity  by dr sonali paradhi mhatre
Retinopathy of prematurity by dr sonali paradhi mhatre
 
RETINOPATHY OF PREMATURITY
RETINOPATHY OF PREMATURITY RETINOPATHY OF PREMATURITY
RETINOPATHY OF PREMATURITY
 
ROP.pptx
ROP.pptxROP.pptx
ROP.pptx
 
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurity
 
Retinopathy Of Prematurity
Retinopathy Of PrematurityRetinopathy Of Prematurity
Retinopathy Of Prematurity
 
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurity
 
Journal reading: Intravitreal bevacizumab for ROP : refractive error results
Journal reading: Intravitreal bevacizumab for ROP : refractive error resultsJournal reading: Intravitreal bevacizumab for ROP : refractive error results
Journal reading: Intravitreal bevacizumab for ROP : refractive error results
 

More from Bipin Koirala

schizophrenia.pptx
schizophrenia.pptxschizophrenia.pptx
schizophrenia.pptx
Bipin Koirala
 
SOFT TORIC CONTACT LENS FITTING.pptx
SOFT TORIC CONTACT LENS FITTING.pptxSOFT TORIC CONTACT LENS FITTING.pptx
SOFT TORIC CONTACT LENS FITTING.pptx
Bipin Koirala
 
corneal ulcer.pptx
corneal ulcer.pptxcorneal ulcer.pptx
corneal ulcer.pptx
Bipin Koirala
 
AGE RELATED CATARCT.pptx
AGE RELATED CATARCT.pptxAGE RELATED CATARCT.pptx
AGE RELATED CATARCT.pptx
Bipin Koirala
 
FACIAL NERVE.pptx
FACIAL NERVE.pptxFACIAL NERVE.pptx
FACIAL NERVE.pptx
Bipin Koirala
 
HYPERTENSIVE RETINOPATHY.pptx
HYPERTENSIVE RETINOPATHY.pptxHYPERTENSIVE RETINOPATHY.pptx
HYPERTENSIVE RETINOPATHY.pptx
Bipin Koirala
 
Evaluation of viterous body.pptx
Evaluation of viterous body.pptxEvaluation of viterous body.pptx
Evaluation of viterous body.pptx
Bipin Koirala
 
REAL THYROID OPHTHALMOPATHY.pptx
REAL THYROID OPHTHALMOPATHY.pptxREAL THYROID OPHTHALMOPATHY.pptx
REAL THYROID OPHTHALMOPATHY.pptx
Bipin Koirala
 
ELEVATION BASED CORNEAL TOPOGRAPHY.pptx
ELEVATION BASED  CORNEAL TOPOGRAPHY.pptxELEVATION BASED  CORNEAL TOPOGRAPHY.pptx
ELEVATION BASED CORNEAL TOPOGRAPHY.pptx
Bipin Koirala
 
Real Refractive error and spectacle correction.ppt
Real Refractive error and spectacle correction.pptReal Refractive error and spectacle correction.ppt
Real Refractive error and spectacle correction.ppt
Bipin Koirala
 
Real ptosis evaluation.pptx
Real ptosis evaluation.pptxReal ptosis evaluation.pptx
Real ptosis evaluation.pptx
Bipin Koirala
 
Types of research design, sampling methods &amp; data collection
Types of research design, sampling methods &amp; data collectionTypes of research design, sampling methods &amp; data collection
Types of research design, sampling methods &amp; data collection
Bipin Koirala
 
Myopia control
Myopia controlMyopia control
Myopia control
Bipin Koirala
 
Real active and passive therapy in amblyopia managament
Real active and passive therapy in amblyopia managamentReal active and passive therapy in amblyopia managament
Real active and passive therapy in amblyopia managament
Bipin Koirala
 
My computer vision syndrome
My computer vision syndromeMy computer vision syndrome
My computer vision syndrome
Bipin Koirala
 
Objective retinoscopy
Objective retinoscopyObjective retinoscopy
Objective retinoscopy
Bipin Koirala
 
My low vision rehabilitation in multiple handicapped patients
My low vision rehabilitation in multiple handicapped patientsMy low vision rehabilitation in multiple handicapped patients
My low vision rehabilitation in multiple handicapped patients
Bipin Koirala
 
Types of pediatric contact lens [autosaved]
Types of pediatric contact lens [autosaved]Types of pediatric contact lens [autosaved]
Types of pediatric contact lens [autosaved]
Bipin Koirala
 
Real computer lens design and applications..
Real computer lens design and applications..Real computer lens design and applications..
Real computer lens design and applications..
Bipin Koirala
 
soft contact lens optics and soft contact lens materials
soft contact lens optics and soft contact lens materialssoft contact lens optics and soft contact lens materials
soft contact lens optics and soft contact lens materials
Bipin Koirala
 

More from Bipin Koirala (20)

schizophrenia.pptx
schizophrenia.pptxschizophrenia.pptx
schizophrenia.pptx
 
SOFT TORIC CONTACT LENS FITTING.pptx
SOFT TORIC CONTACT LENS FITTING.pptxSOFT TORIC CONTACT LENS FITTING.pptx
SOFT TORIC CONTACT LENS FITTING.pptx
 
corneal ulcer.pptx
corneal ulcer.pptxcorneal ulcer.pptx
corneal ulcer.pptx
 
AGE RELATED CATARCT.pptx
AGE RELATED CATARCT.pptxAGE RELATED CATARCT.pptx
AGE RELATED CATARCT.pptx
 
FACIAL NERVE.pptx
FACIAL NERVE.pptxFACIAL NERVE.pptx
FACIAL NERVE.pptx
 
HYPERTENSIVE RETINOPATHY.pptx
HYPERTENSIVE RETINOPATHY.pptxHYPERTENSIVE RETINOPATHY.pptx
HYPERTENSIVE RETINOPATHY.pptx
 
Evaluation of viterous body.pptx
Evaluation of viterous body.pptxEvaluation of viterous body.pptx
Evaluation of viterous body.pptx
 
REAL THYROID OPHTHALMOPATHY.pptx
REAL THYROID OPHTHALMOPATHY.pptxREAL THYROID OPHTHALMOPATHY.pptx
REAL THYROID OPHTHALMOPATHY.pptx
 
ELEVATION BASED CORNEAL TOPOGRAPHY.pptx
ELEVATION BASED  CORNEAL TOPOGRAPHY.pptxELEVATION BASED  CORNEAL TOPOGRAPHY.pptx
ELEVATION BASED CORNEAL TOPOGRAPHY.pptx
 
Real Refractive error and spectacle correction.ppt
Real Refractive error and spectacle correction.pptReal Refractive error and spectacle correction.ppt
Real Refractive error and spectacle correction.ppt
 
Real ptosis evaluation.pptx
Real ptosis evaluation.pptxReal ptosis evaluation.pptx
Real ptosis evaluation.pptx
 
Types of research design, sampling methods &amp; data collection
Types of research design, sampling methods &amp; data collectionTypes of research design, sampling methods &amp; data collection
Types of research design, sampling methods &amp; data collection
 
Myopia control
Myopia controlMyopia control
Myopia control
 
Real active and passive therapy in amblyopia managament
Real active and passive therapy in amblyopia managamentReal active and passive therapy in amblyopia managament
Real active and passive therapy in amblyopia managament
 
My computer vision syndrome
My computer vision syndromeMy computer vision syndrome
My computer vision syndrome
 
Objective retinoscopy
Objective retinoscopyObjective retinoscopy
Objective retinoscopy
 
My low vision rehabilitation in multiple handicapped patients
My low vision rehabilitation in multiple handicapped patientsMy low vision rehabilitation in multiple handicapped patients
My low vision rehabilitation in multiple handicapped patients
 
Types of pediatric contact lens [autosaved]
Types of pediatric contact lens [autosaved]Types of pediatric contact lens [autosaved]
Types of pediatric contact lens [autosaved]
 
Real computer lens design and applications..
Real computer lens design and applications..Real computer lens design and applications..
Real computer lens design and applications..
 
soft contact lens optics and soft contact lens materials
soft contact lens optics and soft contact lens materialssoft contact lens optics and soft contact lens materials
soft contact lens optics and soft contact lens materials
 

Recently uploaded

KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 

Recently uploaded (20)

KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 

Retinopathy of prematurity.pptx

  • 1. BIPIN KOIRALA MASTER’S OF OPTOMETRY HIMALAYA EYE INSTITUTE
  • 2.  Introduction  Epidemiology  Classification  Treatment  References
  • 3.  With the introduction of advanced neonatal life support, survival of preterm neonates has increased significantly.  Prematurity and low birth weight carries a significant risk factor for ocular morbidity.  Retinopathy of prematurity (ROP) is an emerging cause of blindness in the developed country.
  • 4.
  • 5.  Retinopathy of prematurity (ROP) is a bilateral proliferative retinopathy, occurring in premature infants with low birth weight who often have been exposed to high concentration of oxygen.  Well known as Retrolental fibroplasia
  • 6.  ROP, was first correlated with prematurity by Terry in 1942.  Originally described as “Retrolental Fibroplasia”.  The term “ Retinopathy of Prematurity “ was first suggested by Heath in 1952.
  • 7. • Nearly disappeared between 1954-1970, when oxygen use severely restricted. • But now, has returned, secondary to improved neonatal practice of LBW infants.
  • 8.  Every year, an estimated 15 million babies are born preterm (normal gestation is 37– 42 weeks)  Approximately 20,000 of these babies will become blind from retinopathy of prematurity (ROP) every year  An additional 12,300 will be left with visual impairment.
  • 9.  Countries with the highest number of preterm births are India, China, Nigeria, Pakistan and Indonesia.  East Asia, South East Asia, and the Pacific are the regions with the highest number of preterm babies who survive, and the highest number who develop visual loss from ROP
  • 10.  A total of 55 babies fulfilled the screening criteria. ROP was present in 25.45% (n=14) of the babies. Threshold disease was noted in 5.45% (n=3) of the babies screened. Low birth weight (p<0.01) and low gestational age (p<0.01) was significantly associated with the incidence of ROP.  Oxygen supplementation (p=<0.01) was an independent risk factor. Retinopathy of prematurity in a tertiary care hospital in eastern Nepal S Adhikari 1, B P Badhu, N K Bhatta, R S Rajbhandari, B K Kalakheti
  • 11.  Gestational age ( < 32 weeks).  Birth weight of the baby. (< 1500g and especially <1250g).  The amount of time in oxygen therapy.
  • 12.  Sepsis,  Multiple blood transfusions,  Multiple births  Hyaline membrane disease,  Use of Antibiotics,  Apnoea,
  • 13.  Low pH,  Ultraviolet light therapy, etc
  • 14. Various theories proposed are: 1. The Classical Theory 2. Gap Junction Theory 3. Current VEGF Theory
  • 15.  The nasal retina is normally fully vascularized after 8 months of gestation, the temporal periphery at or by 1 month after delivery.  Vascular endothelial growth factor (VEGF) is believed to play an important role in the vascularization process.
  • 16.  Two Process of Vascularization: 1. Vasculogenesis: formation of new vessels by transformation of vascular precursor cells 2. Angiogenesis: budding from existing vessels  Interaction between IGF-1 and VEGF has been studied and proposed to play a role in the pathogenesis of ROP
  • 17.  Hyperoxia in the retina will cause retinal vasoconstriction  If sustained will cause some degree of vascular closure and injury to endothelial cells of the most immature vessels.
  • 18.  It leads to subsequent hypoxia  later with growing age increase in retinal metabolic demand will lead to upsurge of VEGF  leading to abnormal neo vascularization
  • 19.  Nodules of proliferating endothelial cells from residual vascular complexes adjacent to retinal capillaries ablated during hyperoxia canalize to form new vessels  These vessels not only grow within the retina, but also erupt through ILM to grow on its surface.
  • 20.
  • 21.  A circle drawn on the posterior pole, with the optic disc as the centre and twice the discmacula distance as the radius, constitutes zone I.  Any ROP in this zone is usually very severe because of a large peripheral area of avascular retina
  • 22.  A circle is drawn with the optic disc as the centre and disc to nasal Oraserrata as the radius. The area between zone I and this boundary constitutes zone II.
  • 23.  The temporal arc of retina left beyond the radius of zone II is zone III.
  • 24.  The condition has been divided into active ROP and cicatricial ROP.  Clinically the evolution of the active ROP has been divided into five stages ROP STAGE 1 STAGE 2 STAGE 3 STAGE 4 STAGE 5
  • 25.  It is characterised by formation of a demarcation line dividing the vascular from the avascular retina.  It is a thin, flat, tortuous, grey-white line running roughly parallel with the ora serrata.  It is more prominent in the temporal periphery.
  • 26.
  • 27.  Ridge arises in the region of the demarcation line  Ridge is a scar tissue  It has height and width, and extends above the plane of the retina.  Blood vessels enter the ridge and small isolated neovascular tufts may be seen posterior to it
  • 28.
  • 29.  It is characterised by a ridge with extraretinal fibrovascular proliferation into the vitreous.  This stage is further subdivided into mild, moderate and severe, depending on the amount of fibrovascular proliferation.  The highest incidence of this stage is around the post-conceptual age of 35 weeks
  • 30.
  • 31.  It is a stage of subtotal retinal detachment  Sub divided into stage 4a and stage 4b  Stage 4a: It includes subtotal retinal detachment not involving the macula.  Stage 4b: It includes subtotal retinal detachment involving the macula
  • 32.
  • 33.  It is marked by total retinal detachment which is always funnel-shaped.  RD is due to exudation from poorly developed new vessels  RD can also be due to fibro vascular traction
  • 34.
  • 35.  It refers to presence of tortuous dilated vessels at posterior pole with any stage of ROP.  Shows tendency to progress rapidly to Stage 3 (or greater).  Associated with it is the engorgement and dilatation of iris vessels, which result in poor pharmacological dilatation of pupil.
  • 36.
  • 37.  There is a spectrum of abnormal dilatation and tortuosity of which Plus disease is the severe form.  Pre-plus disease was later described as vascular abnormalities of the posterior pole that are insufficient for the diagnosis of plus disease  But that demonstrate more arterial tortuosity and more venous dilatation than normal.
  • 38.
  • 39.  The ETROP trial classified pre threshold ROP into:  Type 1 ROP Zone I, any stage with plus disease. Zone I, stage 3 without plus disease. Zone II, stage 2 or 3 with plus disease..
  • 40. Type 2 disease  Requires observation  Stage 1 or 2 in zone I without plus disease.  Stage 3 ROP within zone II without plus disease.  Treatment is now recommended within 72 hours for prethreshold type I.
  • 41.  Threshold disease refers to stage 3 plus disease involving 5 continuous or 8 discontinuous clock hours.  This stage needs laser or cryotherapy in less than 72 hours
  • 42.
  • 43.  Recommended that a fundus examination be performed on infants:  Who have a gestational age of 30 weeks or less.  A birth weight of less than 1500g.  Birth weight of 1500-2000g with an oxygen supplementation requirement or an unstable course.
  • 44.  The first examination performed at 4 weeks  Or at less than 5 weeks after birth or at a corrected gestational age of 30 to less than 31 weeks, whichever is later.
  • 45.  Follow-up examinations should be done every 1-2 weeks thereafter until retinal vessels have grown normally into zone III  Or until the risk of developing ROP has passed i.e.(about 44 – 46 weeks ).
  • 46.  If the normal blood vessels stop growing into the periphery of the retina  Or if ROP begins to develop, examinations are performed more frequently, either weekly or twice a week.
  • 47.  A lid speculum may be necessary and scleral depression is often required.  Proparacaine can be used to provide topical anesthesia if desired
  • 48.  Pupillary dilatation with one drop each of cyclopentolate 0.5%, phenylephrine 2%  Indirect Ophthalmoscopy with + 20 D
  • 49.  Important to be aware of the infant's status during and immediately after the examination  As the examination can be stressful and be associated with bradycardia
  • 50.
  • 51.  Treatment guidelines are based especially upon  CRYO-ROP study  ETROP STUDY
  • 52.  Cryotherapy ◦ For threshold ROP (stage 3 in at least 5 clock hours with plus disease) ◦ Freezing the sclera with cold probe. ◦ Multiple applications are done to the entire avascular area anterior to the neovascular ridge.
  • 53. Treatment of the ridge itself is avoided, since the ridge tends to bleed and cause vitreous hemorrhage if frozen. Procedure is painful and done under general anesthesia. Complications: Anesthesia problems; Eyelid and conjunctivae edema
  • 54.
  • 55. Laser photocoagulation Laser treatment for ROP is similar to cryotherapy.  The laser spot size is smaller than a spot of cryotherapy. Usually 600-1000 spots of laser as compared to 30-50 spots of cryotherapy needed.
  • 56. Laser is a direct treatment of the retina and its underlying tissue Instead of the entire thickness of the eye wall like in cryotherapy. Most ophthalmologists treating ROP are now using laser.
  • 57.
  • 58.
  • 59. Scleral buckling: For shallow retinal detachment - placing a silicone band around the equator of the eye to relieves the traction of the vitreous gel.
  • 60. Vitrectomy:  For complete retinal detachment.  After the vitreous has been removed, the scar tissue on the retina can be peeled or cut away, allowing the retina to relax and lay back down against the eye wall and to re- attached.
  • 61.  The success rate ranges from 25% to 50% of patients undergoing surgery.  The functional success rate is significantly lower.
  • 62. Intravitreal Injection of Bevacizumab (Avastin).  It has been used for the treatment of ROP but not well established  Zone I disease is more likely to respond than zone II.  Allowing retinal development to proceed normally without the destruction integral to laser treatment is a potential advantage.
  • 63.  Retinal Dragging  Retinal folds  Late onset RD  Glaucoma  Myopia, Strabismus, Amblyopia
  • 64.  Controlling pain,  Careful use of oxygen,  Preventing infection,  Improving nutrition by offering babies breast milk,  Good temperature control and  Supportive practices to keep babies comfortable and stable, such as kangaroo care.
  • 65.  Kanski clinical ophthalmology  AAO eyewiki  Internet sources  Any Questions???
  • 66.
  • 67.  oxygen saturation levels must be monitored and kept at less than 95% to prevent reactive oxygen species-related diseases, such as retinopathy of prematurity and bronchopulmonary dysplasia. At the same time, desaturation below 80 to 85% must be avoided to prevent adverse consequences, such as cerebral palsy. It is still unclear what range of oxygen saturation is appropriate for premature infants; however, until the results of further studies are available, a reasonable target for pulse oxygen saturation (SpO2) is 90 to 93% with an intermittent review of the correlation between SpO2 and the partial pressure of arterial oxygen tension (PaO2).
  • 68.  The experiment consisted of two runs: one was a verbal cognition task, with normal air (21% oxygen) administered and the other was with hyperoxic air (30% oxygen) administered.  Hyper oxic …spo2 increaees

Editor's Notes

  1. Hyaline membrane disease (HMD), also called respiratory distress syndrome (RDS), is a condition that causes babies to need extra oxygen and help breathing. HMD is one of the most common problems seen in premature babies a case of acute lung injury
  2. Phototherapy is treatment with a special type of light (not sunlight). It's sometimes used to treat newborn jaundice by making it easier for your baby's liver to break down and remove the bilirubin from your baby's blood.  A low pH could mean respiratory problems, with the baby suffering a lack of oxygen.
  3. Pretheshold ROP needs very close observation as it can rapidly progress to threshold, which needs prompt treatment
  4. CELLULAR EFFECTS OF CRYOTHERAPY Effects of cryotherapy include: • Ischemia caused by vascular stasis and the destruction of small caliber blood vessels • Ice crystal formation inside cells leading to cell wall rupture • Denaturing of lipid- protein complexes • Osmotic stress • Tissue necrosis • Cellular apoptosis after freezing injury by the buildup of toxic concentrations of solutes inside cells September 09, 2015 Department of Ophthalmology, JNMC, Belagavi 6 7. September 09, 2015 Department of Ophthalmology, JNMC, Belagavi 7 As Cryotherapy freezes extracellular fluid, pure water crystals form extracellularly Thus, concentrating the remaining extracellular solutes The intracellular water is cooling below its freezing point but not forming ice crystals Known as Supercooling Cell membrane is permeable to supercooled water So the supercooled water will tend to flow out of the cell and freeze externally The net result is- • Cellular dehydration • Solute concentration intracellularly
  5.  For Ophthalmological uses the cryogens primarily used for cryotherapy are: • Freon (boiling point = −29.8 ̊C to −40.8 ̊C) • Nitrous oxide (boiling point = −88.5 ̊C) • Solid carbon dioxide (melting point = −79 ̊C) • Liquid nitrogen (boiling point = −195.6 ̊C) Boiling point of liquid nitrogen is by far the lowest, making it the most effective in cell destruction.
  6. Intravitreal Injection of Bevacizumab (Avastin) for Treatment of Stage 3 Retinopathy of Prematurity in Zone I or Posterior Zone II MINTZ-HITTNER, HELEN A. MD*; KUFFEL, RONALD R. JR MD†